Yeh Lab
Located within the UNC Lineberger Comprehensive Cancer Center, the Yeh Lab’s focus is to identify and study novel therapeutic targets for the treatment of pancreatic cancer. Pancreatic cancer in particular continues to be a lethal disease with few therapeutic options. Our research therefore centers on target identification through genomic, and more recently proteomic analyses of patient samples.
Learn More
Research
-
Congratulations Mariaelena
Congratulations to Mariaelena Nabors for her NIH Diversity Supplement Award. She will be studying the role of cingulin in pancreatic cancer.
-
Congratulations Des
Congratulations to Des Weighill, a recipient of the Kenner Family Research Fund Best Paper Awards for the Best Abstracts in Early Detection in Pancreatic Cancer.
-
Congrats Des
Des Weighill, PhD, received The NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers in July 2022. Des has also received the Hopper-Belmont Foundation Inspiration Award in September 2022, and most recently received the APA 2022 Young Investigator Travel Grant. Dr. Des Weighill is a post-doctoral fellow in Yeh lab. Warmest congratulations on … Read more
-
Yi Presents at The AACR Conference
We are so proud of Yi Xu for his fantastic oral presentation at the AACR Pancreatic Cancer Conference, (September 2022)
-
Congratulations to Mariaelena
Congratulations to Mariaelena on The PanCAN Early Career Diversity Underrepresented Minority Travel Scholarship to the AACR Pancreatic Cancer Conference (August 2022)
PANCREATIC CANCER NEWS
- BHLHE40, a potential immune therapy target, regulated by FGD5-AS1/miR-15a-5p in pancreatic cancer
- Cancer-associated fibroblast-related prognostic signature predicts prognosis and immunotherapy response in pancreatic adenocarcinoma based on single-cell and bulk RNA-sequencing
- Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice